Be specific,what trial data was`nt good enough?Because so far there has`nt been any that was bad,and the Cervix data was good enough for the GOG to say what they said.
Spot on! The market worked as intended and now everyone is calling foul. No one here can argue that the capital was used efficiently because it wasn't. So the company got cut off from the market and cheap money.
Now, is it slightly overdone at this point? Sure. But the market worked as intended and no one will trust this company until they can prove the science is desirable and they've changed their ways...